Video: Why the Melbourne Statement?

The Melbourne Consensus Statement on the early detection of prostate cancer

Declan G. Murphy^1,2,3, Thomas Ahlering⁴, William J. Catalona⁵, Helen Crowe^2,3, Jane Crowe³, Noel Clarke¹⁰, Matthew Cooperberg⁶, David Gillatt¹¹, Martin Gleave¹², Stacy Loeb⁷, Monique Roobol¹⁴, Oliver Sartor⁸, Tom Pickles¹³, Addie Wootten³, Patrick C. Walsh⁹ and Anthony J. Costello^2,3

¹Peter MacCallum Cancer Centre, ²Royal Melbourne Hospital, University of Melbourne, ³Epworth Prostate Centre, Australian Prostate Cancer Research Centre, Epworth Healthcare Richmond, Melbourne, Vic., Australia, ⁴School of Medicine, University of California, Irvine, ⁵Northwestern University Feinberg School of Medicine, Chicago, IL, ⁶Helen Diller Family Comprehensive Cancer Centre, University of California, San Francisco, ⁷New York University, ⁸Tulane University School of Medicine, Tulane, ⁹The James Buchanan Brady Urological Institute, Johns Hopkins University, USA, ¹⁰The Christie Hospital, Manchester University, Manchester, ¹¹Bristol Urological Institute, University of Bristol, Bristol, UK, ¹²The Vancouver Prostate Centre, ¹³BC Cancer Agency, University of British Columbia, Vancouver, Canada, and ¹⁴Erasmus University Medical Centre, Rotterdam, The Netherlands

• Various conflicting guidelines and recommendations about prostate cancer screening and early detection have left both clinicians and their patients quite confused. At the Prostate Cancer World Congress held in Melbourne in August 2013, a multidisciplinary group of the world’s leading experts in this area gathered together and generated this set of consensus statements to bring some clarity to this confusion.

• The five consensus statements provide clear guidance for clinicians counselling their patients about the early detection of prostate cancer.